Janet Nale | Microbial Pathogenesis | Innovative Research Award

Posted on by Infectious

Innovative Research Award

Janet Nale
Affiliation Scotland’s Rural College
Country United Kingdom
Scopus ID 55247908300
Documents 25
Citations 821
h-index 13
Subject Area Microbial Pathogenesis
Event International Research Awards on Infectious Diseases
ORCID
0000-0003-0501-7402
Janet Nale
Scotland’s Rural College, United Kingdom

The Innovative Research Award recognizes notable scholarly contributions in the field of microbial pathogenesis and infectious disease research. Janet Nale, affiliated with Scotland’s Rural College in the United Kingdom, has established a recognized academic profile through interdisciplinary research focused on microbial interactions, bacteriophage applications, and pathogenic mechanisms associated with infectious diseases.[1] The researcher has contributed to peer-reviewed scientific literature indexed within major international databases and has demonstrated measurable research impact through citations and collaborative scientific output.[2]

Abstract

This academic profile summarizes the scholarly achievements and scientific contributions of Janet Nale within the discipline of microbial pathogenesis and infectious disease research. The profile highlights research productivity, citation metrics, peer-reviewed publications, and interdisciplinary investigations relevant to microbial interactions and bacteriophage-mediated therapeutic strategies.[2] The documented academic impact reflects sustained engagement in scientific inquiry associated with pathogen control, antimicrobial alternatives, and microbiological innovation within agricultural and biomedical contexts.[3]

Keywords

Microbial Pathogenesis, Infectious Diseases, Bacteriophage Therapy, Antimicrobial Resistance, Veterinary Microbiology, Pathogen Control, Scientific Innovation, Academic Research Impact

Introduction

Research concerning microbial pathogenesis remains a central component of global infectious disease investigations due to the increasing prevalence of antimicrobial resistance and emerging pathogenic threats.[4] Janet Nale has contributed to this field through research associated with bacteriophage biology, pathogen-host interactions, and microbial ecology. The academic contributions linked with Scotland’s Rural College demonstrate engagement in applied microbiological studies with relevance to both veterinary and public health domains.[5]

The researcher’s publication record and citation profile indicate sustained scholarly activity and scientific dissemination within internationally indexed journals. Such contributions align with broader efforts aimed at understanding pathogenic mechanisms and developing alternative antimicrobial interventions in response to evolving infectious disease challenges.[6]

Research Profile

Janet Nale is associated with Scotland’s Rural College in the United Kingdom and maintains a documented scholarly presence within international indexing platforms including Scopus and ORCID.[1] The research profile includes 25 indexed documents, 821 citations, and an h-index of 13, reflecting measurable academic engagement and citation visibility within microbial sciences.[2]

The subject specialization of microbial pathogenesis encompasses investigations into bacterial pathogens, phage-host interactions, microbiological therapeutics, and disease prevention strategies. The researcher’s scientific output demonstrates interdisciplinary integration involving microbiology, molecular biology, infectious disease studies, and veterinary health sciences.[5]

Research Contributions

The research contributions associated with Janet Nale include studies on bacteriophage characterization, antimicrobial alternatives, and pathogen management strategies. Scientific investigations have explored bacteriophage-host interactions relevant to the control of infectious bacterial populations and the mitigation of antimicrobial resistance concerns.[7]

Additional contributions involve collaborative research examining microbial adaptation mechanisms and pathogen ecology within agricultural and biomedical settings. These investigations support broader scientific efforts aimed at developing sustainable and targeted approaches for infectious disease management.[8] The scholarly output reflects continued participation in peer-reviewed scientific communication and interdisciplinary research dissemination.

Publications

Selected publications attributed to Janet Nale include studies concerning bacteriophage applications, microbial pathogen analysis, and therapeutic microbiology. These publications have appeared in peer-reviewed scientific journals focused on microbiology, infectious diseases, and microbial pathogenesis.[7]

  • Research involving bacteriophage-mediated control of pathogenic bacteria and antimicrobial-resistant organisms.[7]
  • Studies examining microbiological interactions relevant to infectious disease transmission and prevention.[8]
  • Collaborative scientific publications associated with veterinary microbiology and pathogen ecology.[5]

Research Impact

The research impact of Janet Nale is reflected through citation metrics, indexed scholarly publications, and interdisciplinary collaborations documented within academic databases.[2] An h-index of 13 indicates a consistent level of citation engagement across multiple publications, while the citation count of 821 demonstrates the relevance of the researcher’s work within microbial pathogenesis and infectious disease studies.[1]

The scientific influence of the researcher is additionally supported by ongoing relevance to antimicrobial resistance research and alternative therapeutic methodologies involving bacteriophages.[6] Such investigations contribute to evolving discussions within microbiology regarding sustainable infectious disease management and pathogen control systems.

Award Suitability

The documented academic profile of Janet Nale demonstrates suitability for recognition within the International Research Awards on Infectious Diseases due to sustained scholarly activity, citation impact, and subject specialization in microbial pathogenesis.[3] The combination of indexed publications, interdisciplinary scientific collaborations, and contributions to bacteriophage research supports the significance of the researcher’s work within contemporary infectious disease studies.[7]

The researcher’s contributions align with the objectives of scientific innovation and evidence-based advancement emphasized within international academic award frameworks. Continued engagement in microbiological and pathogen-focused investigations further supports scholarly recognition in this field.[8]

Conclusion

Janet Nale has developed an established academic profile through contributions to microbial pathogenesis and infectious disease research. The researcher’s publication record, citation metrics, and scientific investigations demonstrate engagement with contemporary microbiological challenges associated with pathogen control and antimicrobial resistance.[2] The overall scholarly profile reflects sustained scientific productivity and interdisciplinary research relevance suitable for academic recognition within international infectious disease award programs.

References

    1. Elsevier. (n.d.). Scopus author details: Janet Nale, Author ID 55247908300. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=55247908300
    2. ORCID. (n.d.). Janet Nale: ORCID researcher profile.
      https://orcid.org/0000-0003-0501-7402
    3. Nale, J. Y., Redgwell, T. A., Millard, A., & Clokie, M. R. J. (n.d.).
      Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model.
      https://pubmed.ncbi.nlm.nih.gov/29438355/
    4. Nale, J. Y., Shan, J., Hickenbotham, P. T., Fawley, W. N., Wilcox, M. H., & Clokie, M. R. J. (n.d.).
      Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains.
      https://pubmed.ncbi.nlm.nih.gov/22624004/
    5. Nale, J. Y., Spencer, J., Hargreaves, K. R., Buckley, A. M., Trzepiński, P., & Douce, G. R. (n.d.).
      Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.
      https://pubmed.ncbi.nlm.nih.gov/26643348/

Nominee | Subject Area | Award Category

Posted on by Infectious

Your Nomination Has Been Selected

Congratulations. Your nomination has been officially approved and selected.
Award profile publication, certification, and verification services
are enabled only after successful registration.

Important: This page is published for registration purposes only.
Public announcement and verification services will be activated after registration.

Free Services Included

  • Nomination acknowledgement
  • Expert review process
  • Published award winners announcement list –

    View list
  • A dedicated nominee details page for verification purposes –

    Sample page

Registration Benefits (Select as You Wish)

  • Profile publication –

    Sample
  • Certification and verification services –

    Sample
  • Printed certificate by post
  • Printed momento by post
  • Online e-certificate download (any time)
  • QR-code verified certificate linked to a public verification page
  • Media posts publication
  • Winners promotional video publication
  • Award event celebrations
  • Global award indexing


Register Here

Digital credentials are typically available within 2–3 working days after registration.
Printed certificates and mementos are dispatched within
30–45 days via secure international air post.

Xin Su | Infectious Diseases | Best Researcher Award

Posted on by Infectious

Dr. Xin Su | Infectious Diseases | Best Researcher Award

Attending Physician | Nanjing University | China

Professor Xin Su, M.D., Ph.D., is a distinguished clinical scientist and Chief Physician renowned for his pioneering contributions to respiratory and critical care medicine, with particular expertise in the study and management of severe pulmonary infections. Over a distinguished career spanning nearly three decades, he has demonstrated an exceptional ability to bridge clinical excellence with translational research innovation. His work focuses on the pathogenesis, diagnosis, and treatment of invasive pulmonary aspergillosis (IPA) in non-neutropenic patients, a challenging and underexplored domain of pulmonary medicine. As a leading investigator, Professor Su has spearheaded multicenter studies that have transformed the understanding of pulmonary fungal infections, combining rigorous clinical observation with the use of novel diagnostic technologies, including machine learning and metagenomic sequencing. His publications in high-impact journals such as The Lancet Infectious Diseases, Microbiology Spectrum, Frontiers in Cellular and Infection Microbiology, and Clinical Microbiology and Infection reflect a deep commitment to advancing evidence-based practices and diagnostic accuracy in the field. Through his groundbreaking studies, Professor Su has introduced innovative diagnostic models that integrate big data analytics with clinical biomarkers, offering more precise and timely identification of IPA and related fungal diseases. Beyond diagnostics, his investigations into host immune responses, interferon signaling, and biomarker development have opened new avenues for prognostic assessment and personalized treatment strategies. His leadership roles as a Chief Physician, Professor, and Doctoral Supervisor at Nanjing University-affiliated hospitals underscore his dual impact as both a clinician and academic mentor. Colleagues and collaborators recognize his unique ability to unite global expertise, as evidenced by his participation in international research consortia addressing fungal infections and severe pneumonia outcomes. His scholarly rigor, coupled with his mentorship of young clinicians and researchers, has significantly enriched the field of respiratory and infectious disease research. While Professor Su’s scientific achievements are substantial, he continues to identify strategic growth areas that align with the evolving challenges of respiratory medicine. Expanding the clinical utility of machine learning-based diagnostic platforms, validating novel biomarkers in diverse patient populations, and enhancing global collaborative networks remain key objectives. Moreover, strengthening translational pathways that connect molecular diagnostics to frontline patient care is an ongoing priority, ensuring that innovations in the laboratory translate into improved clinical outcomes. Looking ahead, Professor Su’s future research aims to deepen the mechanistic understanding of host-pathogen interactions in fungal and viral co-infections, refine AI-driven diagnostic algorithms for pulmonary infections, and integrate multi-omics data into clinical decision-making frameworks. His vision is to establish an internationally recognized precision-medicine model for diagnosing and managing severe respiratory infections, ultimately contributing to reduced mortality, optimized therapeutic strategies, and global health resilience in the era of emerging respiratory pathogens. He has 2677 citations from 128 documents with an h-index of 28.

Profiles: Scopus | ORCID

Publications

1. Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis. (2025). Microbiology Spectrum.

2. Rapid and accurate diagnosis of severe pneumonia: Similarities and differences between severe community-acquired pneumonia and hospital-acquired pneumonia/ventilator-associated pneumonia. (2025). Chinese Journal of Tuberculosis and Respiratory Diseases.

3. Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: A multicenter cohort study. (2025). Microbiology Spectrum.

4. Expert consensus on cancer treatment-related lung injury. (2025). Journal of Thoracic Disease.

5. Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients. (2025). Microbiology Spectrum.

Xuebin Zhang | Surgical Site Infections | Best Researcher Award

Posted on by Infectious

Mr. Xuebin Zhang | Surgical Site Infections | Best Researcher Award 

Associate Chief Physician | Yantai Stomatological Hospital | China

Dr. Xuebin Zhang, currently serving as Associate Chief Physician at Yantai Stomatological Hospital, is a dedicated researcher and clinician specializing in oral and maxillofacial reconstruction with a focus on traditional Chinese medicine–based biomaterials. He holds advanced medical qualifications in stomatology and has built a strong academic foundation through years of clinical and experimental research. Dr. Zhang’s primary research explores the application of Chinese herbal compounds such as naringin and icariin in promoting bone regeneration and accelerating healing of tooth extraction wounds and jaw bone defects. His notable studies include “Evaluation of the Osteogenic Effect of Naringin-Enhanced BMSCs/CPC Composite for Alveolar Ridge Preservation and Tooth Extraction Wound Healing in Beagle Dogs” and “Effects of Naringin on the Proliferation and Osteogenic Differentiation of Canine Bone Marrow Stromal Cells In Vitro”, both published in respected peer-reviewed journals indexed in SCI and PubMed. In recognition of his contributions, he led a Yantai Science and Technology Bureau–funded project on alveolar ridge regeneration. Dr. Zhang also serves as a Young Editor for the Chinese Journal of Medical Humanities, reflecting his growing influence in academic publishing and medical education. His research continues to bridge the gap between traditional Chinese medicine and modern tissue engineering, advancing innovative therapeutic strategies for oral bone reconstruction. Through his scientific rigor, clinical insight, and commitment to translational medicine, Dr. Xuebin Zhang stands out as a promising leader in biomaterial-based oral tissue engineering research. He has 6 citations from 3 documents with an h-index of 2.

Profile: Scopus

Publications

1. Zhang, X., et al. (Year). Evaluation of the osteogenic effect of naringin-enhanced BMSCs/CPC composite for alveolar ridge preservation and tooth extraction wound healing in beagle dogs.

Guang-Yu Pan | Antimicrobial | Best Researcher Award

Posted on by Infectious

Guang-Yu Pan | Antimicrobial | Best Researcher Award

Dr. Guang-Yu Pan, Guilin Medical University, China.

Dr. Guang-Yu Pan is an Associate Professor of Biomedical Engineering at Guilin Medical University, Guilin, China. He earned his Ph.D. from Southeast University in 2018 and joined Guilin Medical University the same year. Promoted to Associate Professor in 2022, Dr. Pan specializes in antimicrobial materials, hemostatic agents, and tissue regeneration materials, addressing critical challenges in healthcare. He has published seven first-author or corresponding-author papers in prestigious international journals, including ACS Applied Nano Materials, Nanoscale, and International Journal of Biological Macromolecules. Dr. Pan’s innovative research continues to advance the frontiers of biomedical engineering.

Professional Profiles

Scopus Profile

Orcid  Profile

📚Education

Dr. Pan completed his Ph.D. in Biomedical Engineering at Southeast University, Nanjing, China, in 2018, focusing on advanced biomaterials for medical applications. He earned his M.Sc. in Biomedical Engineering from the same institution in 2015, specializing in material characterization and biomaterial innovations. He began his academic journey at Guilin Medical University, where he completed his B.Sc. in Biomedical Engineering in 2012, focusing on the fundamentals of medical materials and engineering principles.

💼Experience

Dr. Pan began his professional career at Guilin Medical University in 2018 as a Lecturer in Biomedical Engineering. In 2022, he was promoted to Associate Professor, recognizing his exceptional contributions to research and teaching. His professional experience combines academia, research innovation, and leadership in advancing biomedical solutions.As a dedicated educator, Dr. Pan teaches undergraduate and postgraduate courses in Biomedical Engineering. His teaching focuses on biomaterials, tissue engineering, and the medical applications of material science. He integrates his research findings into the curriculum, providing students with a cutting-edge understanding of the field.

🔬Research Interest

Dr. Pan’s research centers on antimicrobial materials, addressing infections and improving healthcare outcomes. He also focuses on the development of hemostatic agents for effective wound care and the design of innovative biomaterials to support tissue regeneration. His work contributes significantly to the advancement of medical science and technology.

 

👩‍🏫Technical Skills

Dr. Pan is skilled in developing and synthesizing antimicrobial materials and hemostatic agents with applications in wound healing and infection control. He is proficient in designing biomaterials for tissue regeneration and employing advanced techniques for material characterization and biomedical innovations. His expertise bridges material science and healthcare applications.

📑Top Note Publications

Title: A thermoresponsive metabolic nanomodulator for achieving photochemotherapy-sensitized cancer immunotherapy

Authors: Wu, S.-Y.; Zhu, X.-Y.; Zhang, X.; … Xu, B.; Wu, F.-G.
Publication Year: 2024
Citations: 1

Title: Research progress on sensitization mechanism of gemcitabine combined with other drugs in treatment of pancreatic cancer | 吉西他滨联合用药治疗胰腺癌增敏作用机制研究进展

Authors: Liu, M.; Deng, J.; Lei, D.; … Tang, S.; Xie, W.
Publication Year: 2024
Citations: 0

Title: Devastating the Supply Wagons: Multifaceted Liposomes Capable of Exhausting Tumor to Death via Triple Energy Depletion

Authors: Wang, T.-Y.; Zhu, X.-Y.; Jia, H.-R.; … Pan, G.-Y.; Wu, F.-G.
Publication Year: 2024
Citations: 1

Title: Turning dextran into antibacterial fibers: Quaternary ammonium salt for antibacterial treatment and wound healing

Authors: Pan, G.; Wang, Q.; Ding, H.; … Gao, S.; Wang, L.
Publication Year: 2024
Citations: 2

Title: Antioxidant and antibacterial hydrogel formed by protocatechualdehyde–ferric iron complex and aminopolysaccharide for infected wound healing

Authors: Deng, J.; Gao, S.; Liu, M.; Xie, W.; Pan, G.-Y.
Publication Year: 2024
Citations: 1